Supplementary protection
LT - 8-Fluor-2-{4-[(metilamino}metil]fenil}-1,3,4,5-tetrahidro-6H-azepino[5,4,3-cd]indol-6-ono druskos ir polimorfai
EN - SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO}METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE
SPC
| (11) |
Number of the document |
C 2534153 |
| (68) |
Number of the document |
2534153
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2018 517 |
| (22) |
Date of filing the application |
2018-11-15 |
| (41) |
Date of publication of the application |
2018-12-10 |
|
Date of publication of SPC |
2021-03-10 |
| (24) |
Date of coming into effect of SPC |
2031-02-11 |
Applicant
| (71) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
Grantee
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/17/1250, 2018-05-24
|
Calculated date of expiry of the SPC
| (94) |
2033-05-29 |
Name of the product protected by the basic patent
| (95) |
Rukaparibo kamsilatas |
